Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients (Q35833407)

10 August 2017

1 reference

title

Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients (English)

1 reference

10 August 2017

Hamza NS

1

1 reference

10 August 2017

Ghannoum MA

series ordinal

2

1 reference

10 August 2017

Lazarus HM

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Bone Marrow Transplantation

10 August 2017

published in

1 reference

10 August 2017

volume

34

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

377-389

1 reference

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Antifungal chemoprophylaxis after blood and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Diagnosis of fungal infection: new technologies for the mycology laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Invasive mold infections in allogeneic bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Newer antifungal therapy for emerging fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Routine versus selective antifungal administration for control of fungal infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fluconazole in transplant recipients: options and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Cyclophosphamide metabolism is affected by azole antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Detection of Circulating Aspergillus fumigatus Galactomannan: Value and Limits of the Platelia Test for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Diagnosis of fungal infections: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Candida krusei fungemia. An escalating serious infection in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Emerging and less common fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

The exciting future of antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Clinical experience with itraconazole in systemic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

21 January 2018

New antifungal agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

Prevention and therapy of fungal infections in bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

New antifungal agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Aspergillus antigen detection in the diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

The prophylactic use of low-dose amphotericin B in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704603

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704603

1 reference

10 August 2017

1 reference